CTI BIOPHARMA CORP Insider Trading for June 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CTI BIOPHARMA CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in CTI BIOPHARMA CORP for June 2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 06 2014 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Sell | S | 3.00 | 1,800 | 5,400 | 802,897 | 804.7 K to 802.9 K (-0.22 %) |
Jun 06 2014 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Sell | S | 2.99 | 1,100 | 3,289 | 804,697 | 805.8 K to 804.7 K (-0.14 %) |
Jun 06 2014 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Sell | S | 2.98 | 1,100 | 3,278 | 805,797 | 806.9 K to 805.8 K (-0.14 %) |
Jun 06 2014 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Sell | S | 2.97 | 600 | 1,782 | 806,897 | 807.5 K to 806.9 K (-0.07 %) |
Jun 06 2014 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Sell | S | 2.97 | 200 | 593 | 807,497 | 807.7 K to 807.5 K (-0.02 %) |
Jun 06 2014 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Sell | S | 2.96 | 4,200 | 12,432 | 807,697 | 811.9 K to 807.7 K (-0.52 %) |
Jun 06 2014 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Sell | S | 2.95 | 100 | 295 | 811,897 | 812 K to 811.9 K (-0.01 %) |
Jun 06 2014 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Sell | S | 2.95 | 900 | 2,655 | 811,997 | 812.9 K to 812 K (-0.11 %) |
Jun 27 2014 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | President and CEO | Sell | S | 2.84 | 50,000 | 142,000 | 2,297,794 | 2.3 M to 2.3 M (-2.13 %) |
Jun 06 2014 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | President and CEO | Sell | S | 2.99 | 55,000 | 164,450 | 2,347,794 | 2.4 M to 2.3 M (-2.29 %) |
Jun 06 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 3.07 | 200 | 614 | 596,904 | 597.1 K to 596.9 K (-0.03 %) |
Jun 06 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 3.06 | 500 | 1,530 | 597,104 | 597.6 K to 597.1 K (-0.08 %) |
Jun 06 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 3.05 | 700 | 2,135 | 597,604 | 598.3 K to 597.6 K (-0.12 %) |
Jun 06 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 3.05 | 800 | 2,436 | 598,304 | 599.1 K to 598.3 K (-0.13 %) |
Jun 06 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 3.04 | 1,189 | 3,615 | 599,104 | 600.3 K to 599.1 K (-0.20 %) |
Jun 06 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 3.04 | 100 | 304 | 600,293 | 600.4 K to 600.3 K (-0.02 %) |
Jun 06 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 3.03 | 700 | 2,121 | 600,393 | 601.1 K to 600.4 K (-0.12 %) |
Jun 06 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 3.03 | 300 | 908 | 601,093 | 601.4 K to 601.1 K (-0.05 %) |
Jun 06 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 3.02 | 2,300 | 6,946 | 601,393 | 603.7 K to 601.4 K (-0.38 %) |
Jun 06 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 3.02 | 1,200 | 3,618 | 603,693 | 604.9 K to 603.7 K (-0.20 %) |
Jun 06 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 3.01 | 2,100 | 6,321 | 604,893 | 607 K to 604.9 K (-0.35 %) |
Jun 06 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 3.01 | 900 | 2,705 | 606,993 | 607.9 K to 607 K (-0.15 %) |
Jun 06 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 3.00 | 11 | 33 | 607,893 | 607.9 K to 607.9 K (0.00 %) |
Jun 06 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.98 | 300 | 893 | 607,904 | 608.2 K to 607.9 K (-0.05 %) |
Jun 06 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.97 | 700 | 2,079 | 608,204 | 608.9 K to 608.2 K (-0.11 %) |